Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Other Non-Current Liabilities (2018 - 2025)

Historic Other Non-Current Liabilities for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 14 years, with Q2 2025 value amounting to $25.0 million.

  • Lifecore Biomedical, Inc. \De\'s Other Non-Current Liabilities fell 161.02% to $25.0 million in Q2 2025 from the same period last year, while for May 2025 it was $25.0 million, marking a year-over-year decrease of 161.02%. This contributed to the annual value of $25.0 million for FY2025, which is 161.02% down from last year.
  • Lifecore Biomedical, Inc. \De\'s Other Non-Current Liabilities amounted to $25.0 million in Q2 2025, which was down 161.02% from $23.9 million recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Other Non-Current Liabilities ranged from a high of $64.9 million in Q2 2023 and a low of $190000.0 during Q2 2022
  • Its 5-year average for Other Non-Current Liabilities is $18.3 million, with a median of $13.0 million in 2021.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first plummeted by 9337.98% in 2022, then skyrocketed by 3405789.47% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Other Non-Current Liabilities (Quarter) stood at $1.9 million in 2021, then plummeted by 89.6% to $201000.0 in 2022, then soared by 21790.55% to $44.0 million in 2023, then crashed by 47.05% to $23.3 million in 2024, then rose by 7.26% to $25.0 million in 2025.
  • Its Other Non-Current Liabilities stands at $25.0 million for Q2 2025, versus $23.9 million for Q1 2025 and $23.3 million for Q4 2024.